Frontlight ResearchEarly access
Childhood cancers trials in Italy
205 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Bologna, Rome
- Age
- Up to 17 years
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 - Phase 3Not yet taking people in ItalyVO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Where
- Bari, Milan, Modena, Naples, Perugia, Rome, Siena
- Age
- 12 years and over
- People
- 400 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00 - Phase 1/2Taking peopleStudy of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- Where
- Naples, Orbassano, Perugia
- Age
- 12 years and over
- People
- 361 worldwide
- Run by
- ModernaTX, Inc.
See details and how to joinNCT05533697 · EU 2023-504506-11-00 - Phase 3Not yet taking people in ItalyFight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
- Where
- Bologna, Genoa, Milan, Padova, Pisa, Rome, Turin
- People
- 508 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-505575-69-01 - Phase 1/2Taking peopleEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Where
- Genoa, Milan, Turin
- Age
- Up to 18 years
- People
- 472 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT02813135 · EU 2024-514791-40-00 - No phaseNot yet taking people in ItalyTargeting MYC in High-Risk Medulloblastoma
- Where
- Rome
- Age
- Up to 20 years
- People
- 35
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07694622 - No phaseTaking peopleIdentification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
- Where
- Bologna
- People
- 16
- Run by
- Istituto Ortopedico Rizzoli
See details and how to joinNCT07685405 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples, Orbassano, Padova, Pavia, Roma, Torino
- Age
- 12 years and over
- People
- 4,975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Ancona, Aviano, Bari, Bologna, Cagliari, Catania, Florence, Genoa, Milan, Naples, Parma, Rome, Turin, Udine, Verona
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - No phaseTaking peopleBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
- Where
- Perugia, Roma
- People
- 200 worldwide
- Run by
- Immune Oncology Research Institute
See details and how to joinNCT05430971 - No phaseTaking peopleThree miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application
- Where
- Rome
- People
- 10
- Run by
- Regina Elena Cancer Institute
See details and how to joinNCT06883214 - Phase 1/2Active, not recruitingA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Aviano, Milan, Rome
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleRate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience
- Where
- Roma
- People
- 300
- Run by
- Catholic University of the Sacred Heart
See details and how to joinNCT06934863 - No phaseTaking peopleRadiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation
- Where
- Bologna
- People
- 21
- Run by
- Istituto Ortopedico Rizzoli
See details and how to joinNCT06224283 - Phase 3Taking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Ancona, Bari, Bergamo, Catania, Catanzaro, Cosenza, Florence, Genoa, Modena, Monza, Naples, Padova, Palermo, Parma, Perugia, Pescara, Rome, San Giovanni Rotondo, Trieste, Turin, Verona
- Age
- Up to 64 years
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 - No phaseEnrolling by invitationCOLORECTAL CANCER: SINGLE CENTER EXPERIENCE
- Where
- Roma
- People
- 37
- Run by
- University of Roma La Sapienza
See details and how to joinNCT07576049 - Phase 1/2Taking peopleA phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
- Where
- Milan, Rome, Turin
- Age
- Up to 64 years
- People
- 72 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 - Phase 3SuspendedInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Ferrara, Florence, Genoa, Milan, Modena, Monza, Naples, Padova, Palermo, Parma, Pavia, Perugia, Pescara, Pisa, Ravenna, Rome, San Giovanni Rotondo, Trieste, Turin, Varese, Verona
- Age
- Up to 18 years
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00 - Phase 2Taking peopleSafety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
- Where
- Rome
- Age
- 6 months to 17 years
- People
- 31 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508931 · EU 2023-506348-17-00 - No phaseTaking peopleNext Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes
- Where
- Brescia
- People
- 20
- Run by
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
See details and how to joinNCT03058588 - No phaseTaking peopleREal Word aPpLicAtion of Molecular Based Endometrial Cancer Classification
- Where
- Roma
- People
- 264
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07555665 - No phaseTaking peoplePrediction of Germline BRCA 1/2 Genes From Healthy Ovaries
- Where
- Rome
- People
- 6,465
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT05769517 - No phaseTaking peopleCoping and Attachment in Pediatric Oncohematology
- Where
- Monza, Pavia, Taranto
- Age
- 8 years to 17 years
- People
- 60
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06858163 - No phaseTaking peopleRATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
- Where
- Cosenza
- People
- 100 worldwide
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07541521 - Phase 3Taking peopleONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
- Where
- Bologna, Milan, Padova, Rozzano, Turin
- People
- 510 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00